Outcome of patients with Burkitt leukemia/lymphoma and high-grade B-cell lymphoma treated with hyper-CVAD plus rituximab. Overall survival (A) and relapse-free (B) survival according to disease type. Overall survival (C) and relapse-free survival (D) according to age. Overall survival (E) and relapse-free survival (F) according to the status of baseline CNS disease. Cumulative incidence of relapse according to bone marrow involvement (G) and CNS involvement (H). y.o., years old.